Chiemi Hirose

Niigata, 9502181, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

GW240925 and GW250207: Astrophysical Calibration of Gravitational Wave Detectors.

GW240925 and GW250207: Astrophysical Calibration of Gravitational Wave Detectors.

Journal: Physical review letters

Published: January 27, 2026

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Journal: Physical review letters

Published: September 12, 2025

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Journal: Physical review letters

Published: August 13, 2025

Cancer cachexia onset and survival outcomes in metastatic colorectal cancer: Comparative assessment of the asian working group for cachexia and the European palliative care research collaborative criteria, and utility of modified glasgow prognostic score.

Cancer cachexia onset and survival outcomes in metastatic colorectal cancer: Comparative assessment of the asian working group for cachexia and the European palliative care research collaborative criteria, and utility of modified glasgow prognostic score.

Journal: International journal of colorectal disease

Published: July 20, 2025

Geriatric 8 score as a prognostic factor of the efficacy and safety of oxaliplatin-based chemotherapy in elderly patients with metastatic colorectal cancer.

Geriatric 8 score as a prognostic factor of the efficacy and safety of oxaliplatin-based chemotherapy in elderly patients with metastatic colorectal cancer.

Journal: International journal of colorectal disease

Published: May 19, 2025

Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trial.

Mirtazapine plus granisetron and dexamethasone for carboplatin-induced nausea and vomiting in patients with thoracic cancers: A prospective multicenter phase II trial.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 15, 2024

CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy.

CONUT score as a predictor for anamorelin efficacy in patients with cancer cachexia receiving chemotherapy.

Journal: Journal of pharmaceutical health care and sciences

Published: November 21, 2023

Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias.

Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias.

Journal: BMC cancer

Published: June 02, 2023

Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy.

Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy.

Journal: Anticancer research

Published: March 01, 2023

Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy.

Effect of Mirtazapine for the Prevention of Nausea and Vomiting in Patients With Thoracic Cancer Receiving Platinum-based Chemotherapy.

Journal: Anticancer research

Published: January 18, 2023

Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer.

Relationship Between Osimertinib Concentration and Clinical Response in Japanese Patients With Non-small Cell Lung Cancer.

Journal: Anticancer research

Published: December 14, 2022

Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study.

Prognostic Model of Baseline Medications plus Neutrophil-to-lymphocyte Ratio in Patients with Advanced Non-small-cell Lung Cancer Receiving Immune Checkpoint Inhibitor plus Platinum Doublet: A Multicenter Retrospective Study.

Journal: Journal of Cancer

Published: November 04, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026